Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
amplimmune.com

See what CB Insights has to offer

Founded Year

2000

Stage

Acquired | Acquired

Total Raised

$20M

Valuation

$0000 

About Amplimmune Immunology

Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientific founders from Johns Hopkins University have identified several key immunological ligands and receptors. These immunological checkpoint and co-stimulatory molecules are the basis for developing a new class of biological treatments which modulate critical mechanisms in the body's immune system with the aim of bettering the lives of patients suffering from aberrant immunological conditions.

Amplimmune Immunology Headquarter Location

45 West Watkins Mill Road

Gaithersburg, Maryland, 20878,

United States

301-309-9800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Amplimmune Immunology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Amplimmune Immunology is included in 2 Expert Collections, including Cancer.

C

Cancer

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Amplimmune Immunology Patents

Amplimmune Immunology has filed 12 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/27/2014

6/11/2019

Clusters of differentiation, Immunology, Immune system, Transcription factors, Monoclonal antibodies

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/27/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/11/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Clusters of differentiation, Immunology, Immune system, Transcription factors, Monoclonal antibodies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.